Embryonics
Embryonics
AI-powered platform enhancing IVF success rates by analyzing embryo development.
Rate
About
Embryonics is developing novel artificial intelligence (AI) solutions to address the plateauing success rates in the In Vitro Fertilization (IVF) market. By taking a holistic approach, the company aims to improve outcomes by analyzing embryo development and providing expert insights.
Technology stack
detected 2026-06-17Email
Google Workspace
Stack
jQuery
Wix
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Embryonics do?
Embryonics is developing novel artificial intelligence (AI) solutions to address the plateauing success rates in the In Vitro Fertilization (IVF) market. By taking a holistic approach, the company aims to improve outcomes by analyzing embryo development and providing expert insights.
Where is Embryonics headquartered?
Embryonics is headquartered in Tel Aviv, Israel.
When was Embryonics founded?
Embryonics was founded in 2018.
What industry does Embryonics operate in?
Embryonics operates in Healthcare, Medical Imaging, InVitro Fertilization (IVF), HealthTech, MedTech, Biotech.
How many employees does Embryonics have?
Embryonics has approximately 7 people on record.
What is Embryonics's current status?
Embryonics's current operating status is: Inactive.